These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption. Kim MS, Day CJ, Selinger CI, Magno CL, Stephens SR, Morrison NA. J Biol Chem; 2006 Jan 13; 281(2):1274-85. PubMed ID: 16280328 [Abstract] [Full Text] [Related]
3. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells. Kitami S, Tanaka H, Kawato T, Tanabe N, Katono-Tani T, Zhang F, Suzuki N, Yonehara Y, Maeno M. Biochimie; 2010 Apr 13; 92(4):398-404. PubMed ID: 20045440 [Abstract] [Full Text] [Related]
4. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]. Xiao XH, Zhou HD, Yuan LQ, Xie H, Liao EY. Zhonghua Yi Xue Za Zhi; 2004 Dec 17; 84(24):2102-6. PubMed ID: 15730627 [Abstract] [Full Text] [Related]
6. Direct stimulation of osteoclastogenesis by MIP-1alpha: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL. Watanabe T, Kukita T, Kukita A, Wada N, Toh K, Nagata K, Nomiyama H, Iijima T. J Endocrinol; 2004 Jan 17; 180(1):193-201. PubMed ID: 14709158 [Abstract] [Full Text] [Related]
7. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts. Kudo O, Sabokbar A, Pocock A, Itonaga I, Athanasou NA. Calcif Tissue Int; 2002 Dec 17; 71(6):539-46. PubMed ID: 12232680 [Abstract] [Full Text] [Related]
8. Effect of radiation on the expression of osteoclast marker genes in RAW264.7 cells. Yang B, Zhou H, Zhang XD, Liu Z, Fan FY, Sun YM. Mol Med Rep; 2012 Apr 17; 5(4):955-8. PubMed ID: 22294242 [Abstract] [Full Text] [Related]
11. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors. Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H. J Bone Miner Res; 2001 Nov 17; 16(11):2074-81. PubMed ID: 11697804 [Abstract] [Full Text] [Related]
13. A Sub-Clone of RAW264.7-Cells Form Osteoclast-Like Cells Capable of Bone Resorption Faster than Parental RAW264.7 through Increased De Novo Expression and Nuclear Translocation of NFATc1. Mira-Pascual L, Tran AN, Andersson G, Näreoja T, Lång P. Int J Mol Sci; 2020 Jan 14; 21(2):. PubMed ID: 31947698 [Abstract] [Full Text] [Related]
14. YY1 is involved in RANKL-induced transcription of the tartrate-resistant acid phosphatase gene in osteoclast differentiation. Shi Z, Silveira A, Patel P, Feng X. Gene; 2004 Dec 08; 343(1):117-26. PubMed ID: 15563837 [Abstract] [Full Text] [Related]
15. Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration. Voronov I, Heersche JN, Casper RF, Tenenbaum HC, Manolson MF. Biochem Pharmacol; 2005 Jul 15; 70(2):300-7. PubMed ID: 15919055 [Abstract] [Full Text] [Related]